Editas Medicine (EDIT) Non-Current Assets (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Non-Current Assets data on file, last reported at $22.6 million in Q4 2025.

• On a quarterly basis, Non-Current Assets fell 56.69% year-over-year to $22.6 million in Q4 2025; TTM through Dec 2025 was $114.1 million, a 66.63% decrease from a year earlier, with the FY2025 full-year figure at $22.6 million, down 56.69% from the prior year.
• Non-Current Assets for Q4 2025 stood at $22.6 million, down from $24.9 million in the prior quarter.
• Over the last five years, Non-Current Assets for EDIT reached as high as $170.2 million in Q4 2021 and fell as low as $22.6 million in Q4 2025.
• Historically, Non-Current Assets has averaged $105.8 million across 5 years, with a median of $122.8 million in 2022.
• Across the five-year window, Non-Current Assets surged 255.45% in 2021 and tumbled 71.78% in 2025, its largest moves.
• Year by year, Non-Current Assets stood at $170.2 million in 2021, then declined by 7.41% to $157.6 million in 2022, then advanced by 0.48% to $158.3 million in 2023, then tumbled by 66.98% to $52.3 million in 2024, then sank by 56.69% to $22.6 million in 2025.
• Per Business Quant data, the three most recent Non-Current Assets figures were $22.6 million in Q4 2025, $24.9 million in Q3 2025, and $27.8 million in Q2 2025.